Semaglutide is everywhere — headlines, social feeds, waiting rooms. But how does it actually work? And what do the clinical numbers really mean when you look past the before-and-after photos?
Free Resource
Get the free Peptide Starter Guide
BPC-157, Semaglutide, TB-500, GHK-Cu, Thymosin Alpha-1 — what the research says and how to source safely. Straight to your inbox.
🔒 No spam. Unsubscribe anytime.
Semaglutide is a GLP-1 receptor agonist. The STEP trials showed 15–17% average body weight loss over 68 weeks. The SELECT trial showed a 20% reduction in major cardiovascular events. The mechanism is real. The results are real. The conversation starts with a doctor.
For the complete breakdown including mechanism, side effect management, and what tirzepatide changed: Understanding Semaglutide: Beyond the Weight Loss Headlines →